Truist Financial reissued their buy rating on shares of Glaukos (NYSE:GKOS – Free Report) in a research report released on Thursday morning, Benzinga reports. Truist Financial currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $120.00. A number of other research firms also recently commented […]
Glaukos Co. (NYSE:GKOS – Get Free Report)’s stock price gapped up prior to trading on Monday . The stock had previously closed at $106.51, but opened at $110.00. Glaukos shares last traded at $109.82, with a volume of 104,331 shares trading hands. Analyst Ratings Changes A number of equities research analysts have weighed in on […]
Glaukos (NYSE:GKOS – Get Free Report) announced its earnings results on Wednesday. The medical instruments supplier reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.58) by ($0.12), Briefing.com reports. Glaukos had a negative net margin of 43.15% and a negative return on equity of 24.69%. The company had revenue of $85.60 million […]
Glaukos (NYSE:GKOS – Get Free Report) released its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.58) by ($0.12), Briefing.com reports. Glaukos had a negative return on equity of 24.69% and a negative net margin of 43.15%. The business had […]
Glaukos (NYSE:GKOS – Get Free Report) had its price objective upped by stock analysts at JPMorgan Chase & Co. from $108.00 to $110.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. JPMorgan Chase & Co.‘s target price would suggest a […]